CHRISTINE FARINA: Open Payments
NPI 1346842234 · CLEARWATER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,142 in 51 payments from 10 companies in 2025. Trend: 2023 $3,179 · 2024 $2,506 · 2025 $1,142
Food & beverage: $1,142
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 26 | $242 |
| Axsome Therapeutics, Inc. | 2 | $219 |
| Teva Pharmaceuticals USA, Inc. | 10 | $211 |
| ABBVIE INC. | 3 | $182 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $115 |
| Alkermes, Inc. | 4 | $88 |
| E.R. Squibb & Sons, L.L.C. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Lundbeck LLC | 1 | $18 |
Products named: INGREZZA, Auvelity, AUSTEDO XR, VRAYLAR, CAPLYTA, ARISTADA, COBENFY, ABILIFY MAINTENA.
Industry payments across FL — which companies pay providers there.
